Over the past few decades, Pharmacovigilance (PV), has been instrumental in detecting, assessing, understanding and preventing adverse events. In the due course, drug manufacturing organizations have implemented safety and PV systems with due diligence to stay compliant with Health Authority (HA) requirements.
Will it be a sigh of relief for drug makers?
March 10, 2015 Regulatory Affairs
Why a Company Core Data Sheet (CCDS) is required and what is its significance for the marketing authorization holders (MAH).